Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4604770 | 0.86 | MAPT (0.44) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL136602 | 0.86 | MAPT (0.49) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL10309089 | 0.86 | MAPT (0.49) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL29450242 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL1865228 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| Hydrochloric Acid SCHEMBL4604209 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| Bromide SCHEMBL4604526 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL29099250 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| Iodide SCHEMBL29362949 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT | |
| SCHEMBL6853538 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8702815-B2 | Cyanoborate, fluoroalkylphosphate, fluoroalkylborate or imide dyes | MERCK PATENT GMBH (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20110190480-A1 | CYANOBORATE, FLUOROALKYLPHOSPHATE, FLUOROALKYLBORATE OR IMIDE DYES | IGNATYEV NIKOLAI MYKOLA | 2011-08-04 | — | — | US | disclosed |
| US-7939644-B2 | cationic dyes used for coloring plastics, fibers, leather and paper, for the preparation of flexographic printing inks, as ball-point pen pastes, as stamp inks, for use in data acquisition systems, reprography, in ink microfilters, in photogalvanics, laser technology and the photo industry | MERCK PATENT GMBH (DE) | 2011-05-10 | — | — | US | disclosed |
| US-20080275224-A1 | Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes | MERCK PATENT GMBH (DE) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190480-A1 | CYANOBORATE, FLUOROALKYLPHOSPHATE, FLUOROALKYLBORATE OR IMIDE DYES | ZAP70, MYLK3, KIT | MAPT 3351/4885MEN1 4104/4885KMT2A 823/4885 |
| US-20080275224-A1 | Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes | ZAP70, MYLK3, KIT | MAPT 3351/4885MEN1 4104/4885KMT2A 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.